Literature DB >> 34993499

100 Years of Insulin: Lifesaver, immune target, and potential remedy for prevention.

Anette-Gabriele Ziegler1,2,3,4, Thomas Danne5, Carolin Daniel1,2,6, Ezio Bonifacio7,8.   

Abstract

In this review, we bring our personal experiences to showcase insulin from its breakthrough discovery as a life-saving drug 100 years ago to its uncovering as the autoantigen and potential cause of type 1 diabetes and eventually as an opportunity to prevent autoimmune diabetes. The work covers the birth of insulin to treat patients, which is now 100 years ago, the development of human insulin, insulin analogues, devices, and the way into automated insulin delivery, the realization that insulin is the primary autoimmune target of type 1 diabetes in children, novel approaches of immunotherapy using insulin for immune tolerance induction, the possible limitations of insulin immunotherapy, and an outlook how modern vaccines could remove the need for another 100 years of insulin therapy.

Entities:  

Keywords:  Autoimmunity; Automated Insulin Delivery; Insulin; Insulin Autoantibody; Insulin Immunotherapy; Insulin device; Insulin pump; Tolerance; Treg; Type 1 Diabetes

Mesh:

Substances:

Year:  2021        PMID: 34993499      PMCID: PMC8730368          DOI: 10.1016/j.medj.2021.08.003

Source DB:  PubMed          Journal:  Med (N Y)        ISSN: 2666-6340


  129 in total

1.  Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice.

Authors:  D G Karounos; J S Bryson; D A Cohen
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 2.  Current practice of insulin pump therapy in children and adolescents - the Hannover recipe.

Authors:  Thomas Danne; Wolfgang von Schütz; Karin Lange; Claudia Nestoris; Nicolin Datz; Olga Kordonouri
Journal:  Pediatr Diabetes       Date:  2006-08       Impact factor: 4.866

3.  Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes.

Authors:  Revital Nimri; Tadej Battelino; Lori M Laffel; Robert H Slover; Desmond Schatz; Stuart A Weinzimer; Klemen Dovc; Thomas Danne; Moshe Phillip
Journal:  Nat Med       Date:  2020-09-09       Impact factor: 53.440

4.  Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.

Authors:  M W Sadelain; H Y Qin; J Lauzon; B Singh
Journal:  Diabetes       Date:  1990-05       Impact factor: 9.461

5.  Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes.

Authors:  Thomas Danne; Reinhard H A Becker; Tim Heise; Claudia Bittner; Annke D Frick; Klaus Rave
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

6.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

7.  Determinants of glycaemic outcome in the current practice of care for young people up to 21 years old with type 1 diabetes under real-life conditions.

Authors:  O Kordonouri; K Lange; T Biester; N Datz; K Kapitzke; T von dem Berge; J Weiskorn; T Danne
Journal:  Diabet Med       Date:  2019-09-23       Impact factor: 4.359

8.  Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Follow-up of the Berlin Retinopathy Study.

Authors:  T Danne; B Weber; R Hartmann; I Enders; W Burger; G Hovener
Journal:  Diabetes Care       Date:  1994-12       Impact factor: 19.112

9.  Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.

Authors:  E Bonifacio; P J Bingley; M Shattock; B M Dean; D Dunger; E A Gale; G F Bottazzo
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

10.  A Decade of Disparities in Diabetes Technology Use and HbA1c in Pediatric Type 1 Diabetes: A Transatlantic Comparison.

Authors:  Ananta Addala; Marie Auzanneau; Kellee Miller; Werner Maier; Nicole Foster; Thomas Kapellen; Ashby Walker; Joachim Rosenbauer; David M Maahs; Reinhard W Holl
Journal:  Diabetes Care       Date:  2020-09-16       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.